The estimated Net Worth of Roxanne Lagano is at least $14.4 Milion dollars as of 18 April 2024. Ms. Lagano owns over 923 units of Zoetis Inc stock worth over $2,811,852 and over the last 12 years she sold ZTS stock worth over $11,607,862. In addition, she makes $0 as Chief Human Resource Officer i Executive Vice President and Global Operations at Zoetis Inc.
Roxanne has made over 46 trades of the Zoetis Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently she sold 923 units of ZTS stock worth $139,530 on 18 April 2024.
The largest trade she's ever made was exercising 35,663 units of Zoetis Inc stock on 21 February 2018 worth over $927,238. On average, Roxanne trades about 2,013 units every 32 days since 2013. As of 18 April 2024 she still owns at least 14,800 units of Zoetis Inc stock.
You can see the complete history of Ms. Lagano stock trades at the bottom of the page.
Roxanne Lagano serves as Chief Human Resource Officer, Executive Vice President and Global Operations of the Company. Ms. Lagano has served as our Executive Vice President and Chief Human Resources Officer since November 2012 and was given responsibility for the Global Operations and Security functions in January 2020. She previously had oversight of the company’s Corporate Communications function from 2015 to 2019. Prior to joining Zoetis, Ms. Lagano was Senior Vice President, Global Compensation, Benefits and Wellness for Pfizer. Ms. Lagano joined Pfizer in 1997 and held various positions, including Senior Director, Business Transactions, Pfizer Worldwide Human Resources.
Roxanne Lagano is 55, she's been the Chief Human Resource Officer i Executive Vice President and Global Operations of Zoetis Inc since 2020. There are 14 older and 9 younger executives at Zoetis Inc. The oldest executive at Zoetis Inc is William Steere, 83, who is the Independent Director.
Roxanne's mailing address filed with the SEC is C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY, NJ, 07054.
Over the last 12 years, insiders at Zoetis Inc have traded over $876,669,659 worth of Zoetis Inc stock and bought 1,602,140 units worth $77,083,975 . The most active insiders traders include Square Capital Management, ..., Frank A Damelio oraz Michael B Mccallister. On average, Zoetis Inc executives and independent directors trade stock every 14 days with the average trade being worth of $14,414,921. The most recent stock trade was executed by Soria Ester Banque on 31 July 2024, trading 895 units of ZTS stock currently worth $170,041.
Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.
Zoetis Inc executives and other stock owners filed with the SEC include: